Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A

Published:2014-04-03 Issue:5 Volume:20 Page:624-629
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Aznar J. A.¹²,Moret A.¹,Ibáñez F.³,Vila C.¹,Cabrera N.¹,Mesa E.¹,Bonanad S.¹

Affiliation:

1. Hemostasis and Thrombosis Unit; La Fe University and Polytechnical Hospital; Valencia Spain

2. Health Investigation Institute; La Fe University and Polytechnical Hospital; Valencia Spain

3. Hematology Unit; General Hospital of Requena; Requena Spain

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12439/fullpdf

Reference31 articles.

1. Coagulation Disorders

2. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders;United Kingdom Haemophilia Centre Doctor's Organisation;Haemophilia,2003

3. Immunogenicity of factor VIII concentrates in patients with hemophilia: a randomized clinical trial is warranted;Gringeri;Blood,2007

4. Epidemiology of inhibitors in haemophilia A;Kreuz;Vox Sang,1996

5. The epidemiology of inhibitors in haemophilia A: a systematic review;Wight;Haemophilia,2003

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patients;Haemophilia;2023-06-05

2. An update of the current pharmacotherapeutic armamentarium for hemophilia A;Expert Opinion on Pharmacotherapy;2021-08-18

3. The inhibitors – a challenge for the management of patients with hereditary haemophilia A;Romanian Journal of Internal Medicine;2018-08-29

4. A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third-generation B-domain-deleted recombinant factor VIII;Haemophilia;2018-02-01

5. Inhibitors in Hemophilia A: A Pharmacoeconomic Perspective;Seminars in Thrombosis and Hemostasis;2017-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3